Zelalem Temesgen, MD
Infectious Disease · Rochester, MNNPI 1528030335
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $43,805 of the $46,384 with a category attached, or 94.4%. Viiv Healthcare Company accounts for 94.4% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $11,210 and has fallen 98.8% since, to $129 in 2025. Among infectious disease clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 40 payments — averaging $1159.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$44K
- Theratechnologies Inc.$3K
- Gilead$100
Across 9 payments — averaging $4972.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$22K
- Emergent Biosolutions Inc.$20K
- Pfizer$2K
What the payments were for
- Consulting fees$43,80594%
- Travel & lodging$1,5473%
- Food & beverage$1,0332%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 36 | $43,784 |
| Theratechnologies Inc. | 2 | $2,500 |
| Gilead | 2 | $100 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$46,384 in reported general payments places this provider in the 95th percentile of 157 infectious disease providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Rochester
- Nathan CumminsRochester$44K
- Andrew BadleyRochester$22K
- Raymund RazonableRochester$20K
- Marisa AzadRochester$17K
- Priya SampathkumarRochester$13K
- Paschalis VergidisRochester$10K
- Abinash VirkRochester$6K
- Larry BaddourRochester$5K
- Aditya ShahRochester$4K
- Sapna SadaranganiRochester$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.